Global Cord Blood Corpora... (CO)
NYSE: CO
· Real-Time Price · USD
2.99
0.77 (34.68%)
At close: Jun 09, 2023, 3:43 PM
Global Cord Blood Income Statement
Financials in CNY. Fiscal
year is
April - March.
Fiscal Year | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jul 5, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Revenue | 1.23B | 1.24B | 1.25B | 1.22B | 1.19B | 1.16B | 1.16B | 1.2B | 1.23B |
Cost of Revenue | 177.44M | 183.31M | 187.24M | 184.84M | 183.32M | 178.95M | 176.5M | 183.22M | 186.84M |
Gross Profit | 1.05B | 1.06B | 1.06B | 1.04B | 1.01B | 980.69M | 980.71M | 1.02B | 1.04B |
Operating Income | 594.45M | 608.87M | 614.97M | 589.21M | 567.92M | 544.87M | 545.97M | 574.88M | 580.16M |
Interest Income | 24.42M | 32.61M | 32.31M | 31.5M | 32.32M | 30.9M | 29.05M | 28.21M | 25.91M |
Pretax Income | 595.65M | 627.84M | 642.49M | 622.74M | 622.56M | 610.75M | 589.48M | 621.91M | 609.85M |
Net Income | 471.44M | 501.06M | 524.08M | 506.46M | 512.16M | 508.25M | 477.52M | 505.96M | 494.88M |
Selling & General & Admin | 312.46M | 428.79M | 423.16M | 422.78M | 418.14M | 412.05M | 412.86M | 423.73M | 441.25M |
Research & Development | 12.42M | 22.3M | 23M | 25.14M | 24.52M | 23.77M | 21.89M | 19.31M | 20.75M |
Other Expenses | 583K | 1.22M | 1.22M | 1.22M | 639K | n/a | n/a | n/a | 422K |
Operating Expenses | 324.88M | 451.08M | 446.16M | 447.92M | 442.66M | 435.82M | 434.74M | 443.03M | 462M |
Interest Expense | 6.23M | 4.16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 122.84M | 241.72M | 241.76M | 244.83M | 242.03M | 237.69M | 238.68M | 245.63M | 256.38M |
Cost & Expenses | 502.32M | 634.39M | 633.4M | 632.75M | 625.98M | 614.77M | 611.24M | 626.26M | 648.84M |
Income Tax Expense | 118.35M | 118.35M | 109.5M | 107.15M | 101.79M | 94.55M | 104.01M | 108.43M | 107.63M |
Shares Outstanding (Basic) | 121.76M | 121.76M | 120.89M | 122.07M | 121.8M | 121.65M | 121.43M | 121.7M | 121.57M |
Shares Outstanding (Diluted) | 121.76M | 121.76M | 120.89M | 122.07M | 121.8M | 121.65M | 121.43M | 121.7M | 121.57M |
EPS (Basic) | 3.89 | 4.13 | 4.32 | 4.16 | 4.21 | 4.18 | 3.93 | 4.16 | 4.07 |
EPS (Diluted) | 3.89 | 4.13 | 4.32 | 4.16 | 4.21 | 4.18 | 3.93 | 4.16 | 4.07 |
EBITDA | 610.25M | 637.79M | 633.58M | 613.61M | 613.95M | 602.79M | 581.53M | 614.39M | 602.51M |
EBIT | 597.89M | 612.31M | 616.34M | 589.21M | 567.92M | 544.87M | 565.75M | 594.66M | 599.93M |
Depreciation & Amortization | 15.84M | 28.93M | 18.61M | 24.41M | 46.03M | 57.92M | 35.56M | 39.51M | 22.36M |